Bathgate
Andrew Bathgate, Orinda, CA US
Patent application number | Description | Published |
---|---|---|
20100318893 | Online document annotation and reading system - An online system provides users with tools to annotate publications and share such annotations with other users. Publications annotated by a community of users become a richer source of information for the community. | 12-16-2010 |
Emma Bathgate, London GB
Patent application number | Description | Published |
---|---|---|
20150033292 | Method and System for Sharing and Distributing Content - A system for distributing content to at least one client device is disclosed. A content host has a processor and a content store, a client device has a processor and a content cache and a permissions store has a computer storage device configured to store permissions data corresponding to a recipient of content. The content host processor is configured to receive a content identifier corresponding to a recipient request for permission to cache an item of content. The content host processor will then parse the permissions data to determine if the recipient has available permissions to cache the requested content. If the user has available permissions, the content host processor modifies the permissions data to include permission to cache the content. The recipient may additionally request for permission to cache a given item of content to be removed in order to increase an amount of permissions available to the recipient. | 01-29-2015 |
Lee Bathgate, Dunfermline GB
Patent application number | Description | Published |
---|---|---|
20130336494 | AGC Circuit for an Echo Cancelling Circuit - An amplifier circuit and a method of amplification using automatic gain control (AGC) are disclosed. A method for reducing distortions incurred by an audio signal when being rendered by an electronic device is described. The method comprises receiving an input signal; determining signal strength; determining a frequency-dependent AGC filter; wherein the frequency-dependent AGC filter is adapted to selectively attenuate the input signal within a number N of predetermined frequency ranges, according to corresponding N degrees of attenuation; wherein N predetermined frequency ranges depend upon a rendering characteristic of the electronic device; and wherein the N-degrees of attenuation depend upon the signal strength; and attenuating the input signal using the frequency-dependent AGC filter to obtain an output signal for rendering by the electronic device. | 12-19-2013 |
Ross Bathgate, Victoria AU
Patent application number | Description | Published |
---|---|---|
20140179540 | MODIFYING PROTEINS (GPCR), LIGANDS, AND NANOPORE SURFACES TO ALLOW THE DETECTION OF CREATE BINDING-INDUCED MOLECULAR CHANGES OF PROTEIN-LIGAND COMPLEXES WITH NANOCHANNEL TRANSLOCATION - A mechanism is provided for utilizing a nanodevice to distinguish molecules with different structure. The molecules translocate through or across a nanochannel filled with a electrolyte solution. An electrical signal through the nanochannel is measured for every translocation event. Inner surfaces of the nanochannel include a functional layer, which is a coating to functionalize the nanochannel, in which the functional layer is configured to interact with predetermined ones of the molecules during translocation events. It is determined that a combination of at least two different molecules is formed based on predetermined ones of the molecules interacting with the functional layer to change the electrical signal and/or change a translocation time for the translocation event. | 06-26-2014 |
20140179541 | MODIFYING SINGLE PROTEINS (GPCR), LIGANDS, AND NANOPORE SURFACES TO CREATE BINDING-INDUCED MOLECULAR CHANGES OF PROTEIN-LIGAND COMPLEXES DETECTED IN NANOCHANNEL TRANSLOCATION - A mechanism is provided for utilizing a nanodevice to distinguish molecules with different structure. The molecules translocate through or across a nanochannel filled with a electrolyte solution. An electrical signal through the nanochannel is measured for every translocation event. Inner surfaces of the nanochannel include a functional layer, which is a coating to functionalize the nanochannel, in which the functional layer is configured to interact with predetermined ones of the molecules during translocation events. It is determined that a combination of at least two different molecules is formed based on predetermined ones of the molecules interacting with the functional layer to change the electrical signal and/or change a translocation time for the translocation event. | 06-26-2014 |
Ross Alexander David Bathgate, Moonee Ponds AU
Patent application number | Description | Published |
---|---|---|
20140024592 | Modified Relaxin Polypeptides - The present invention relates to biologically active relaxin polypeptides comprising a relaxin A chain and a B chain derived from a relaxin superfamily member, wherein the A chain comprises no intra-chain disulphide bonds. In particular embodiments the modified polypeptides comprise relaxin-3 derived A and B chains, and truncations of the A and/or B chains from the N-termini and/or C-termini. In particular embodiments the polypeptides of the invention are selective agonists or antagonists of the RXFP3 receptor. | 01-23-2014 |
20140038895 | Single Chain Relaxin Polypeptides - The present invention relates to biologically active single chain relaxin polypeptides comprising a relaxin B chain derived from relaxin-3, the polypeptides being truncated by one or more amino acids at the C-terminus of the relaxin-3 B chain. Typically the single chain relaxin polypeptides are antagonists of the RXFP3 receptor, and in some embodiments are selective antagonists of the RXFP3 receptor. | 02-06-2014 |
Ross Alexander David Bathgate, Brunswick West AU
Patent application number | Description | Published |
---|---|---|
20090239805 | HUMAN 3 RELAXIN - Human H3 preprorelaxin, human H3 prorelaxin, human H3 relaxin, human relaxin analogues having a modified A chain and/or a modified B chain are described. Also described are nucleic acid sequences encoded human H3 preprorelaxin, human H3 prorelaxin, human H3 relaxin, human relaxin analogues. Also described are methods for the treatment of conditions responsive to administration of H3 relaxin or analogues thereof. | 09-24-2009 |
20110003750 | HUMAN 3 RELAXIN - Human H3 preprorelaxin, human H3 prorelaxin, human H3 relaxin, human relaxin analogues having a modified A chain and/or a modified B chain are described. Also described are nucleic acid sequences encoded human H3 preprorelaxin, human H3 prorelaxin, human H3 relaxin, human relaxin analogues. Also described are methods for the treatment of conditions responsive to administration of H3 relaxin or analogues thereof. | 01-06-2011 |
Ross Alexander David Bathgate, Victoria AU
Patent application number | Description | Published |
---|---|---|
20110092418 | Chimeric Relaxin Polypeptides Comprising an A and B Chain Derived From Different Relaxin Family Peptides - Provided herein are modified relaxin polypeptides wherein the B chain comprises the core amino acid sequence CGR-XXX-R-XX-I/V-XX-CG (SEQ ID NO:1), where X is any amino acid. Also provided are modified relaxin polypeptides comprising at least an A and a B chain, wherein the A and B chains are derived from different naturally occurring relaxins and wherein the B chain comprises the core amino acid sequence CGR-XXX-R-XX-I/V-XX-CG (SEQ ID NO:1), where X is any amino acid. | 04-21-2011 |